Salix Pharmaceuticals (SLXP): Q1 EPS of $0.67 beats by $0.11. Revenue of $171.1M (+62% Y/Y). (PR)

|About: Salix Pharmaceuticals, Ltd. (SLXP)|By:, SA News Editor
Salix Pharmaceuticals (SLXP): Q1 EPS of $0.67 beats by $0.11. Revenue of $171.1M (+62% Y/Y). (PR)